Part 2. Faculty/Presenter Disclosure Faculty/Presenter:[insert name here] Relationships with commercial interests: Grants/research support:[insert company/organization.

Slides:

Advertisements

Similar presentations

Faculty/Presenter Disclosure Faculty: [Speaker’s name] Relationships with commercial interests: – Grants/Research Support: PharmaCorp ABC – Speakers Bureau/Honoraria:

Advertisements

To be at the very first slide at the beginning of event WELCOME (may include your dates, logo of organization, etc.) Slide 1.

Expanding a Regional-based Program: Resource Matching and Referral and the Inter-LHIN Referral Model May 28 th, 2013.

Pain Management Module Learning Session 1.

Sample Disclosure Slides Information: A presenter must include Disclosure slides for each presentation – even if nothing to disclose Two slides are required.

Faculty/Presenter Disclosure Faculty: [name of speaker(s)] Relationships with commercial interests:  Grants/Research Support:  Speakers Bureau/Honoraria:

ACCREDITATION CRITERIA CONFLICT OF INTEREST CONTENT INTEGRITY.

Arya M Sharma, MD, FRCPC Chair in Obesity Research & Management University of Alberta Medical Director Alberta Provincial Obesity Program Edmonton, AB,

Presentation Title Speaker Name. Conflict of Interest Disclosures for Speakers 1. I do not have any relationships with any entities producing, marketing,

Presentation Title Speaker Name. Conflict of Interest Disclosures for Speakers 1. I do not have any potential conflicts to disclose. 2. I wish to disclose.

May Use Organization Required Slide Here Name Title Company Name.

Faculty/Presenter Disclosure Slide 1 Faculty: [Speaker’s name] Relationships with commercial interests: – Grants/Research Support: PharmaCorp ABC – Speakers.

Financial Interest Disclosure (over the past 24 months) Commercial Interest Relationship Company A advisory board, consultant, investigator Company B speaker.

Pain Management BounceBack Learning Session 3 Presenter’s name here Location here Date here.

Slide 1: Faculty/Presenter Disclosure

Faculty Disclosure Information

Faculty/Presenter Disclosure

PRESENTATION NUMBER: PRESENTATION TITLE PRESENTER Author Block.

Arthritis and Low Back Pain

HOW LOW SHOULD YOU TARGET LDL-C?

Details of Potential Conflict

Name of Program Date.

Faculty/Presenter Disclosure

Disclosure Relevant relationships with commercial entities:

Disclosure of Affiliations, Financial Support, and Mitigating Bias Speaker Name: Session Information: (Program Name, Session Title, Date) Affiliations:

HOW LOW SHOULD YOU TARGET LDL-C?

SLIDE 1: Scientific Planning Committee(SPC) / Organizing Planning Committee (OPC) Disclosure SPC/OPC Name Relationships with for-profit and/or non-profit.

Title of the presentation

Insert Your Photo or Logo Here

Disclosure Information 87th Annual Scientific Meeting Speaker’s Name Here I have the following financial relationships to disclose: (select those that.

Speaker Disclosure In accordance with the policy of the Thoracic Society of Australia and New Zealand the following presenter has indicated that they have.

Conflict of Interest Disclosure:

Disclosure Information 89th Annual Scientific Meeting I have the following financial relationships to disclose: (select those that.

Group Medical Visits Health Literacy Patient Self-Management

Faculty/Presenter Disclosure

Presenter Disclosure Presenters: [Speaker’s name]

Westin Wall Centre – Airport Ballroom

Disclosure of Affiliations, Financial Support, and Mitigating Bias Speaker Name: Affiliations: Please choose the statement that best describes your disclosure:

Presenter Disclosure Presenters: [Speaker’s name]

Conflict of Interest Disclosure (over the past 24 months)

Faculty/Presenter Disclosure

FIRST LAST Name Title of Session Title of Presentation.

Click to edit title Click to edit subtitle

Speaker Disclosure In accordance with the policy of the Thoracic Society of Australia and New Zealand the following presenter has indicated that they have.

Faculty/Presenter Disclosure

Faculty/Presenter Disclosure Relationships with commercial interests:

MSK TTT 2 October 23, 2013 Dr. Julia Alleyne

Disclosure of Faculty Conflict of Interest

Faculty/Presenter Disclosure

Faculty/Presenter Disclosure Slide 1

Presentation Title Subtitle.

Presentation Title Speaker Name.

Faculty/Presenter Disclosure

Faculty/Presenter Disclosure

Disclosure Information 90th Annual Scientific Meeting I have the following financial relationships to disclose: (select those that.

Presenter Disclosure Dr. First Name Last Name – Presenter

Faculty/Presenter Disclosure

Title of the presentation

Faculty/Presenter Disclosure

Faculty/Presenter DISCLOSURE:

Faculty/Presenter Disclosure

TITLE & AUTHORS Presenter Name, Institution, Country.

Conflict of Interest Disclosures insert speaker’s name here

Conflict of Interest Disclosure Form DISCLOSURE

Name of Activity / Session

Faculty/Presenter Disclosure

Faculty / Presenter Disclosure

Faculty/Presenter Disclosure

Presentation transcript:

Part 2

Faculty/Presenter Disclosure Faculty/Presenter:[insert name here] Relationships with commercial interests: Grants/research support:[insert company/organization name(s) here] Speaker’s bureau/honoraria:[insert company/organization name(s) here] Consulting fees:[insert company/organization name(s) here] Other:[insert company/organization name(s) here]

Disclosure of Commercial Support This program has received financial support from AstraZeneca Canada Inc. in the form of an educational grant This program has received in-kind support from AstraZeneca Canada Inc. in the form of logistical support Potential for conflict(s) of interest: [Faculty/speaker name] has received [payment/funding] from [organization supporting the program AND/OR organization whose product(s) are being discussed in this program] AstraZeneca Canada Inc. markets or benefits from the sale of a product(s) that will be discussed in this program: exenatide (Byetta), saxagliptin (Onglyza)

Mitigating Potential Bias Potential sources of bias identified in the preceding 2 slides have been mitigated as follows: Information presented is evidence-based Recommendations made are evidence- or guidelines-based rather than personal recommendations of the presenter Material has been reviewed by an Educational Committee responsible for overseeing the program’s Needs Assessment and subsequent content development